35.
Cats A, Kuipers EJ, Bosschaert MA, Pot RG, Vandenbroucke-Grauls CM, Kusters JG. Effect of frequent consumption of a Lactobacillus casei-containing milk drink in Helicobacter pylori-colonized subjects. Aliment Pharmacol Ther. 2003;17:429–35.PubMed
36.
Ushiyama A, Tanaka K, Aiba Y, Shiba T, Takagi A, et al. Lactobacillus gasseri OLL2716 as a probiotic in clarithromycin-resistant Helicobacter pylori infection. J Gastroenterol Hepatol. 2003;18:986–91.PubMed
37.
Collado MC, González A, González R, Hernández M, Ferrús MA, Sanz Y. Antimicrobial peptides are among the antagonistic metabolites produced by Bifidobacterium against Helicobacter pylori. Int J Antimicrob Agents. 2005;25:385–91.PubMed
38.
Alfaleh K, Anabrees J, Bassler D. Probiotics reduce the risk of necrotizing enterocolitis in preterm infants: a meta-analysis. Neonatology. 2010;97:93–9.PubMed
39.
Weber TK, Polanco I. Gastrointestinal microbiota and some children diseases: a review. Gastroenterol Res Pract. 2012;2012:676585.PubMedCentralPubMed
40.
Santos F, Vera JL, van der Heijden R, Valdez G, de Vos WM, Sesma F, et al. The complete coenzyme B12 biosynthesis gene cluster of Lactobacillus reuteri CRL1098. Microbiology. 2008;154:81–93.PubMed
41.
Fabian E, Majchrzak D, Dieminger B, Meyer E, Elmadfa I. Influence of probiotic and conventional yoghurt on the status of vitamins B1, B2 and B6 in young healthy women. Ann Nutr Metab. 2008;52:29–36.PubMed
42.
de Vrese M, Stegelmann A, Richter B, Fenselau S, Laue C, Schrezenmeir J. Probiotics—compensation for lactase insufficiency. Am J Clin Nutr. 2001;73(2 Suppl):421S–9S.PubMed
43.
Sousa T, Paterson R, Moore V, Carlsson A, Abrahamsson B, Basit AW. The gastrointestinal microbiota as a site for the biotransformation of drugs. Int J Pharm. 2008;363:1–25.PubMed
44.
Fischbach MA. Antibiotics from microbes: converging to kill. Curr Opin Microbiol. 2009;12:520–7.PubMedCentralPubMed
45.
Gorissen L, Raes K, Weckx S, Dannenberger D, Leroy F, De Vuyst L, et al. Production of conjugated linoleic acid and conjugated linolenic acid isomers by Bifidobacterium species. Appl Microbiol Biotechnol. 2010;87:2257–66.PubMed
46.
Ando A, Ogawa J, Kishino S, Shimizu S. CLA production from ricinoleic acid by lactic acid bacteria. J Am Oil Chem Soc. 2003;80:889–94.
47.
Decroos K, Vanhemmens S, Cattoir S, Boon N, Verstraete W. Isolation and characterisation of an equol-producing mixed microbial culture from a human faecal sample and its activity under gastrointestinal conditions. Arch Microbiol. 2005;183:45–55.PubMed
48.
Possemiers S, Rabot S, Espín JC, Bruneau A, Philippe C, González-Sarrías A, et al. Eubacterium limosum activates isoxanthohumol from hops (Humulus lupulus L.) into the potent phytoestrogen 8-prenylnaringenin in vitro and in rat intestine. J Nutr. 2008;138:1310–6.PubMed
49.
Hamilton-Miller JM. Probiotics and prebiotics in the elderly. Postgrad Med J. 2004;80:447–51.PubMedCentralPubMed
50.
Borthakur A, Gill RK, Tyagi S, Koutsouris A, Alrefai WA, Hecht GA, et al. The probiotic Lactobacillus acidophilus stimulates chloride/hydroxyl exchange activity in human intestinal epithelial cells. J Nutr. 2008;138:1355–9.PubMedCentralPubMed
51.
De Boever P, Wouters R, Verschaeve L, Berckmans P, Schoeters G, Verstraete W. Protective effect of the bile salt hydrolase-active Lactobacillus reuteri against bile salt cytotoxicity. Appl Microbiol Biotechnol. 2000;53:709–14.PubMed
52.
De Smet I, De Boever P, Verstraete W. Cholesterol lowering in pigs through enhanced bacterial bile salt hydrolase activity. Br J Nutr. 1998;79:185–94.PubMed
53.
Gratz S, Mykkänen H, Ouwehand AC, Juvonen R, Salminen S, El-Nezami H. Intestinal mucus alters the ability of probiotic bacteria to bind aflatoxin B1 in vitro. Appl Environ Microbiol. 2004;70:6306–8.PubMedCentralPubMed
54.
Kabeerdoss J, Devi RS, Mary RR, Prabhavathi D, Vidya R, Mechenro J, et al. Effect of yoghurt containing Bifidobacterium lactis Bb12® on faecal excretion of secretory immunoglobulin A and human beta-defensin 2 in healthy adult volunteers. Nutr J. 2011;10:138.PubMedCentralPubMed
55.
Ghadimi D, Fölster-Holst R, de Vrese M, Winkler P, Heller KJ, Schrezenmeir J. Effects of probiotic bacteria and their genomic DNA on TH1/TH2-cytokine production by peripheral blood mononuclear cells (PBMCs) of healthy and allergic subjects. Immunobiology. 2008;213:677–92.PubMed
56.
Saavedra JM, Bauman NA, Oung I, Perman JA, Yolken RH. Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus. Lancet. 1994;344:1046–9.PubMed
57.
Szajewska H, Kotowska M, Mrukowicz JZ, Armanska M, Mikolajczyk W. Efficacy of Lactobacillus GG in prevention of nosocomial diarrhea in infants. J Pediatr. 2001;138:361–5.PubMed
58.
Mastretta E Longo P, Laccisaglia A, Balbo L, Russo R, Mazzaccara A, Gianino P. Effect of a Lactobacillus GG and breast-feeding in the prevention of rotavirus nosocomial infection. J Pediatr Gastroenterol Nutr. 2002;35:527–31.PubMed
59.
Szajewska H, Setty M, Mrukowicz J, Guandalini S. Probiotics in gastrointestinal disease in children: hard and not-so-hard evidence of efficacy. J Pediatr Gastroenterol Nutr. 2006;42:454–75.PubMed
60.
Agustina R, Kok FJ, van de Rest O, Fahmida U, Firmansyah A, Lukito W, et al. Randomized trial of probiotics and calcium on diarrhea and respiratory tract infections in Indonesian children. Pediatrics. 2012;129:e1155–64.PubMed
61.
Guandalini S. Probiotics for prevention and treatment of diarrhea. J Clin Gastroenterol. 2011;45 Suppl:S149–53.
62.
Szajewska H, Mrukowicz JZ. Use of probiotics in children with acute diarrhea. Paediatr Drugs. 2005;7:111–22.PubMed
63.
Chouraqui JP, Van Egroo LD, Fichot MC. Acidified milk formula supplemented with Bifidobacterium lactis: impact on infant diarrhea in residual care settings. J Pediatr Gastroenterol Nutr. 2004;38:288–92.PubMed
64.
Thibault H, Aubert-Jacquin C, Goulet O. Effects of long-term consumption of a fermented infant formula (with Bifidoacterium Breve c50 and Streptococcus thermophilus 065) on acute diarrhea in healthy infants. J Pediatr Gastroenterol Nutr. 2004;39:147–52.PubMed
65.
Wanke M, Szajewska H. Lack of an effect of Lactobacillus reuteri DSM 17938 in preventing nosocomial diarrhea in children: a randomized, double-blind, placebo-controlled trial. J Pediatr. 2012;161:40–3.PubMed
66.
Szajewska H, Guarino A, Hojsak I, Indrio F, Kolacek S, Shamir R, et al., on behalf of the ESPGHAN Working Group for Probiotics/Prebiotics. The use of probiotics for the management of acute gastroenteritis. A position paper by the ESPGHAN working group for Probiotics. J Pediatr Gastroenterol Nutr. 2014;58:531–9.
67.
Lund B, Edlund C. Probiotic Enterococcus faecium strain is a possible recipient of the vanA gene cluster. Clin Infect Dis. 2001;32:1384–5.PubMed
68.
Hempel S, Newberry SJ, Maher AR, Wang Z, Miles JN, Shanman R, et al. Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. JAMA. 2012;307:1959–69.PubMed
69.
Videlock EJ, Cremonini F. Meta-analysis: probiotics in antibiotic-associated diarrhoea. Aliment Pharmacol Ther. 2012;35:1355–69.PubMed
70.
Sazawal S, Hiremath G, Dhingra U, Malik P, Deb S, Black RE. Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebo-controlled trials. Lancet Infect Dis. 2006;6:374–82.PubMed
71.
McFarland LV. Meta-analysis of probiotics for prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease. Am J Gastroenterol. 2006;101:812–22.PubMed
72.
Johnston BC, Goldenberg JZ, Vandvik PO, Sun X, Guyatt GH. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst Rev. 2011;9(11):CD004827. doi: 10.1002/14651858.CD004827.pub3.
73.
Tung JM, Dolovich LR, Lee CH. Prevention of Clostridium difficile infection with Saccharomyces boulardii: a systematic review. Can J Gastroenterol. 2009;23:817–21.PubMedCentralPubMed
74.
Pozzoni P, Riva A, Bellatorre AG, Amigoni M, Redaelli E, Ronchetti A, et al. Saccharomyces boulardii for the prevention of antibiotic-associated diarrhea in adult hospitalized patients: a single-center, randomized, double-blind, placebo-controlled trial. Am J Gastroenterol. 2012;107:922–31.PubMed
< div class='tao-gold-member'>
Only gold members can continue reading. Log In or Register a > to continue